ArcticZymes Technologies ASA

Historical price data

ArcticZymes Technologies is a mission-driven company focused on advancing molecular research, diagnostics, and therapeutics through specialized enzymatic solutions derived from Arctic organisms. Its key achievement is the invention of salt-active nucleases and COD UNG, establishing it as a critical supplier to the global IVD and biomanufacturing industries. The company's strategy is to deepen its penetration in the high-growth gene therapy and vaccine manufacturing markets while expanding its therapeutic pipeline. With over 30 years of expertise, ArcticZymes combines a stable commercial enzyme business with a forward-looking therapeutic development arm.

A proprietary Cold-Adapted Enzyme Discovery & Optimization Platform that harnesses extremozymes from Arctic microorganisms, yielding enzymes with unique properties like thermolability, cold-activity, and salt-tolerance for research, diagnostics, and therapeutics.

Competes against broad-line life science tool giants (Thermo Fisher, Merck) through deep specialization in high-performance, cold-adapted enzymes. In biomanufacturing, its Salt-Active Nucleases directly challenge the established standard (Benzonase®) by offering superior performance in high-salt purification processes critical for advanced therapies.